{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:49:57Z","timestamp":1787320197587,"version":"build-2736575974"},"reference-count":47,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&amp;D (CSRD)","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"Biomedical Laboratory R&amp;D (BLRD) Service","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"Rehabilitation R&amp;D (RRD)","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"Department of Defense Gulf War Illness Research Program (GWIRP)","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]},{"name":"Vision Research Program (VRP)","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"Vision Research Program (VRP)","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"Vision Research Program (VRP)","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"Vision Research Program (VRP)","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"Vision Research Program (VRP)","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"Vision Research Program (VRP)","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"Vision Research Program (VRP)","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"Vision Research Program (VRP)","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"Vision Research Program (VRP)","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH Center Core","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"NIH Center Core","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"NIH Center Core","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"NIH Center Core","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"NIH Center Core","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"NIH Center Core","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"NIH Center Core","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"NIH Center Core","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"NIH Center Core","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["I21 RX003883"],"award-info":[{"award-number":["I21 RX003883"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["U01EY034686"],"award-info":[{"award-number":["U01EY034686"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}]},{"name":"Research to Prevent Blindness Unrestricted","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Dry eye disease is an umbrella term that includes a variety of symptoms and signs. A link between diabetes mellitus and dry eye disease exists, but the associated phenotype needs further examination. Thus, our aim was to determine how diabetes mellitus relates to the dry eye disease phenotype. A prospective, cross-sectional study was conducted at the Miami Veteran Affairs Medical Center ophthalmology clinic between October 2013 and September 2019. Participants included a volunteer sample of 366 South Florida veterans with one or more symptoms or signs of dry eye disease [Dry Eye Questionnaire-5 \u2265 6 OR tear break-up time \u2264 5 OR Schirmer\u2019s test score \u2264 5 OR corneal fluorescein staining \u2265 2]. Participants were divided into three groups: (1) individuals without diabetes mellitus (controls); (2) individuals with diabetes mellitus but without end-organ complications; and (3) individuals with diabetes mellitus and end-organ complications. Dry eye metrics were compared across groups. The main outcome measures included ocular symptom questionnaires [e.g., 5-item Dry Eye Questionnaire, Ocular Surface Disease Index, and ocular pain assessment] and clinical parameters obtained from an ocular surface evaluation. A total of 366 individuals were included (mean age 59 \u00b1 6 years; 89% males; 39% White; 11% diabetes mellitus and end-organ complications; 15% diabetes mellitus but without end-organ complications). Individuals with diabetes mellitus and end-organ complications had lower symptom scores on the dry eye disease and pain-specific questionnaires compared to individuals with diabetes mellitus but without end-organ complications and controls (Ocular Surface Disease Index: 42.1 \u00b1 24.5 vs. 38.9 \u00b1 25.1 vs. 23.6 \u00b1 16.2; p &lt; 0.001; numerical rating scale of ocular pain intensity: 4.9 \u00b1 3.2 vs. 4.3 \u00b1 2.7 vs. 3.5 \u00b1 2.7; p = 0.02). Eyelid laxity was also more severe in the group with diabetes mellitus and end-organ complications (0.69 \u00b1 0.64 vs. 0.73 \u00b1 0.72 vs. 1.08 \u00b1 0.77; p = 0.004) compared to the two other groups. The diabetic dry eye disease phenotype is driven by signs more so than by symptoms, with anatomic eyelid abnormalities being more frequent in individuals with diabetes mellitus and end-organ complications. Given this, ocular surface abnormalities in individuals with DM may be missed if screened by symptoms alone. As such, individuals with DM should undergo a slit lamp examination for signs of ocular surface disease, including anatomic abnormalities.<\/jats:p>","DOI":"10.3390\/jcm12206535","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:47:32Z","timestamp":1697366852000},"page":"6535","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Individuals with Diabetes Mellitus Have a Dry Eye Phenotype Driven by Low Symptom Burden and Anatomic Abnormalities"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-7196","authenticated-orcid":false,"given":"Elyana V. T.","family":"Locatelli","sequence":"first","affiliation":[{"name":"Surgical and Research Services, Miami Veterans Affairs Medical Center, Miami, FL 33125, USA"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaxon J.","family":"Huang","sequence":"additional","affiliation":[{"name":"Surgical and Research Services, Miami Veterans Affairs Medical Center, Miami, FL 33125, USA"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-3353","authenticated-orcid":false,"given":"Simran","family":"Mangwani-Mordani","sequence":"additional","affiliation":[{"name":"Surgical and Research Services, Miami Veterans Affairs Medical Center, Miami, FL 33125, USA"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna A.","family":"Tovar Vetencourt","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[{"name":"Surgical and Research Services, Miami Veterans Affairs Medical Center, Miami, FL 33125, USA"},{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08164622.2021.1962210","article-title":"Beyond dry eye: How co-morbidities influence disease phenotype in dry eye disease","volume":"105","author":"Lee","year":"2022","journal-title":"Clin. Exp. Optom."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II Report Executive Summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e000697","DOI":"10.1136\/bmjophth-2020-000697","article-title":"Dry eye: Why artificial tears are not always the answer","volume":"6","author":"Kim","year":"2021","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_4","first-page":"T4","article-title":"Discordant Dry Eye Disease (An American Ophthalmological Society Thesis)","volume":"114","author":"Shtein","year":"2016","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ajo.2011.11.030","article-title":"Impact of ocular surface symptoms on quality of life in a United States veterans affairs population","volume":"153","author":"Pouyeh","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"DES138","DOI":"10.1167\/iovs.17-23765","article-title":"Systemic Health and Dry Eye","volume":"59","author":"Kawashima","year":"2018","journal-title":"Inv. Ophthalmol. Vis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology Report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8201053","DOI":"10.1155\/2016\/8201053","article-title":"Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics","volume":"2016","author":"Zhang","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jdiacomp.2013.04.006","article-title":"Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus","volume":"27","author":"Najafi","year":"2013","journal-title":"J. Diabetes Complicat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-8227(02)00244-9","article-title":"Risk factors for ocular surface disorders in patients with diabetes mellitus","volume":"59","author":"Ozdemir","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(00)00599-6","article-title":"Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus","volume":"108","author":"Dogru","year":"2001","journal-title":"Ophthalmology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/OPTH.S184173","article-title":"Patient-reported severity of dry eye and quality of life in diabetes","volume":"13","author":"Han","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pcd.2020.01.011","article-title":"Dry eyes in patients with diabetes mellitus","volume":"15","author":"Ferraz","year":"2021","journal-title":"Prim. Care Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"An, Q., and Zou, H. (2022). Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients. Crit. Rev. Microbiol., 1\u201310.","DOI":"10.1080\/1040841X.2022.2142090"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3047867","DOI":"10.1155\/2017\/3047867","article-title":"Meibomian Gland Dysfunction in Type 2 Diabetic Patients","volume":"2017","author":"Lin","year":"2017","journal-title":"J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1103400","DOI":"10.3389\/fmed.2023.1103400","article-title":"Dry eye disease severity and impact on quality of life in type II diabetes mellitus","volume":"10","author":"Zhmud","year":"2023","journal-title":"Front. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses","volume":"33","author":"Chalmers","year":"2010","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/j.pain.0000000000001552","article-title":"Modification of the Neuropathic Pain Symptom Inventory for use in eye pain (NPSI-Eye)","volume":"160","author":"Farhangi","year":"2019","journal-title":"Pain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1167\/iovs.15-18133","article-title":"Corneal Mechanical Thresholds Negatively Associate With Dry Eye and Ocular Pain Symptoms","volume":"57","author":"Spierer","year":"2016","journal-title":"Inv. Ophthalmol. Vis. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/OPX.0b013e31828aaf10","article-title":"In situ osmometry: Validation and effect of sample collection technique","volume":"90","author":"Gokhale","year":"2013","journal-title":"Optom. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/ICO.0000000000000286","article-title":"Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population","volume":"34","author":"Ansari","year":"2015","journal-title":"Cornea"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","article-title":"Meibomian gland dysfunction: A clinical scheme for description, diagnosis, classification, and grading","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocul. Surf."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"(2007). Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 108\u2013152.","DOI":"10.1016\/S1542-0124(12)70083-6"},{"key":"ref_27","first-page":"588","article-title":"An Assement of Subjective and Objective Grading of Meibography Images","volume":"53","author":"Pult","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1167\/iovs.11-9228","article-title":"Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain","volume":"53","author":"Viso","year":"2012","journal-title":"Inv. Ophthalmol. Vis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1167\/iovs.14-15200","article-title":"The heritability of dry eye disease in a female twin cohort","volume":"55","author":"Vehof","year":"2014","journal-title":"Inv. Ophthalmol. Vis. Sci."},{"key":"ref_30","first-page":"7644","article-title":"Expression of SIRT1 and oxidative stress in diabetic dry eye","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1079541","DOI":"10.3389\/fendo.2022.1079541","article-title":"Mechanistic investigations of diabetic ocular surface diseases","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12020-009-9208-9","article-title":"Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats","volume":"36","author":"Modulo","year":"2009","journal-title":"Endocrine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"732887","DOI":"10.3389\/fphar.2021.732887","article-title":"Recent Developments About the Pathogenesis of Dry Eye Disease: Based on Immune Inflammatory Mechanisms","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: Sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Du, C., Whiddett, R.O., Buckle, I., Chen, C., Forbes, J.M., and Fotheringham, A.K. (2022). Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells, 11.","DOI":"10.3390\/cells11213503"},{"key":"ref_36","first-page":"1576","article-title":"Advanced glycation end product (AGE) modified proteins in tears of diabetic patients","volume":"16","author":"Zhao","year":"2010","journal-title":"Mol. Vis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1167\/iovs.19-26928","article-title":"Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye","volume":"60","author":"Qu","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1167\/iovs.14-16259","article-title":"Poly(ADP-Ribose) Polymerase Inhibition Improves Corneal Epithelial Innervation and Wound Healing in Diabetic Rats","volume":"56","author":"Byun","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1097\/ICL.0000000000000375","article-title":"Sub-basal Corneal Nerve Plexus Analysis Using a New Software Technology","volume":"44","author":"Batawi","year":"2018","journal-title":"Eye Contact Lens"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3341\/kjo.2004.18.2.168","article-title":"Changes of tear film and ocular surface in diabetes mellitus","volume":"18","author":"Yoon","year":"2004","journal-title":"Korean J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ICO.0000000000000786","article-title":"Impact of Eyelid Laxity on Symptoms and Signs of Dry Eye Disease","volume":"35","author":"Chhadva","year":"2016","journal-title":"Cornea"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.sleep.2005.07.001","article-title":"Floppy eyelid syndrome: Clinical features and the association with obstructive sleep apnea","volume":"7","author":"Leibovitch","year":"2006","journal-title":"Sleep. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11686-021-00382-8","article-title":"A Survey on How Ocular Surface Demodex Infestation Interactively Associates with Diabetes Mellitus and Dry Eye Disease","volume":"66","author":"Huang","year":"2021","journal-title":"Acta Parasitol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/OPTH.S114674","article-title":"DEBS-a unification theory for dry eye and blepharitis","volume":"10","author":"Rynerson","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jop.2021.0083","article-title":"Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study","volume":"38","author":"Zhang","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/archophthalmol.2009.270","article-title":"Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus","volume":"127","author":"Zagon","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e2232584","DOI":"10.1001\/jamanetworkopen.2022.32584","article-title":"Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs. Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan","volume":"5","author":"Su","year":"2022","journal-title":"JAMA Netw. Open"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/20\/6535\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:07:09Z","timestamp":1760130429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/20\/6535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":47,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["jcm12206535"],"URL":"https:\/\/doi.org\/10.3390\/jcm12206535","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,15]]}}}